Invitrogen LentiArray CRISPR Libraries

Organization: Thermo Fisher Scientific
Year: 2018

The Invitrogen LentiArray CRISPR Libraries allow researchers to completely knock out entire panels of genes, increasing both the quality and efficiency of their screening experiments. Capitalizing on the power of CRISPR-Cas9 technology for high-throughput applications, the Libraries give researchers a new set of tools to rapidly identify key therapeutic targets and understand complex biological pathways. This allows researchers to determine which genes are key members of specific biological pathways and whether they are involved in disease development or progression. The Libraries’ proprietary design algorithm has been engineered to provide optimal gRNA designs by predicated editing efficiency and off-target effects. It includes 19 predefined libraries and custom options, giving endusers flexibility in their assay design.

For more info: